Haemonetics Corp (HAE) stock
HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q1 FY2027, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3077% above fair value
$122.86+1.94 (+1.60%)
Close on Nov 18, 2026Market cap $5.59BP/E 59.9Yield –
Haemonetics net income
Net income is the profit left for shareholders after every expense, interest and tax.
Haemonetics's net income for the twelve months ending Jun 27, 2026 was $96.29M, down 41.1% year over year. For fiscal 2026 it was $97.31M, down 42.0% from the year before. The highest annual figure on record is $167.68M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 28, 2026 | $97.31M | -42.0% |
| FY2025 | Mar 29, 2025 | $167.68M | +42.6% |
| FY2024 | Mar 30, 2024 | $117.56M | +1.9% |
| FY2023 | Apr 1, 2023 | $115.40M | +166.1% |
| FY2022 | Apr 2, 2022 | $43.38M | -45.4% |
| FY2021 | Apr 3, 2021 | $79.47M | +3.8% |
| FY2020 | Mar 28, 2020 | $76.53M | +39.1% |
| FY2019 | Mar 30, 2019 | $55.02M | +20.7% |
| FY2018 | Mar 31, 2018 | $45.57M | – |
| FY2017 | Apr 1, 2017 | -$26.27M | – |
| FY2016 | Apr 2, 2016 | -$55.58M | -428.9% |
| FY2015 | Mar 28, 2015 | $16.90M | -51.9% |
| FY2014 | Mar 29, 2014 | $35.15M | -9.4% |
| FY2013 | Mar 30, 2013 | $38.80M | -42.0% |
| FY2012 | Mar 31, 2012 | $66.89M | -16.4% |
| FY2011 | Apr 2, 2011 | $79.98M | +37.0% |
| FY2010 | Apr 3, 2010 | $58.37M | -1.6% |
| FY2009 | Mar 28, 2009 | $59.30M | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 27, 2026 | $33.01M | -3.0% |
| Q4 FY2026CQ1 2026 | Mar 28, 2026 | -$20.15M | -134.7% |
| Q3 FY2026CQ4 2025 | Dec 27, 2025 | $44.74M | +19.3% |
| Q2 FY2026CQ3 2025 | Sep 27, 2025 | $38.68M | +14.3% |
| Q1 FY2026CQ2 2025 | Jun 28, 2025 | $34.03M | -11.3% |
| Q4 FY2025CQ1 2025 | Mar 29, 2025 | $57.98M | +184.7% |
| Q3 FY2025CQ4 2024 | Dec 28, 2024 | $37.49M | +20.0% |
| Q2 FY2025CQ3 2024 | Sep 28, 2024 | $33.83M | +35.8% |
| Q1 FY2025CQ2 2024 | Jun 29, 2024 | $38.37M | -6.5% |
| Q4 FY2024CQ1 2024 | Mar 30, 2024 | $20.37M | -30.7% |
| Q3 FY2024CQ4 2023 | Dec 30, 2023 | $31.24M | -5.2% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $24.91M | -25.0% |
| Q1 FY2024CQ2 2023 | Jul 1, 2023 | $41.04M | +106.5% |
| Q4 FY2023CQ1 2023 | Apr 1, 2023 | $29.38M | +201.6% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $32.94M | +41.8% |
| Q2 FY2023CQ3 2022 | Oct 1, 2022 | $33.20M | +123.5% |
| Q1 FY2023CQ2 2022 | Jul 2, 2022 | $19.88M | – |
| Q4 FY2022CQ1 2022 | Apr 2, 2022 | $9.74M | – |
| Q3 FY2022CQ4 2021 | Jan 1, 2022 | $23.23M | -27.1% |
| Q2 FY2022CQ3 2021 | Oct 2, 2021 | $14.86M | -69.1% |
| Q1 FY2022CQ2 2021 | Jul 3, 2021 | -$4.45M | -142.3% |
| Q4 FY2021CQ1 2021 | Apr 3, 2021 | -$11.04M | -162.6% |
| Q3 FY2021CQ4 2020 | Dec 26, 2020 | $31.88M | +6.6% |
| Q2 FY2021CQ3 2020 | Sep 26, 2020 | $48.10M | +28.3% |
| Q1 FY2021CQ2 2020 | Jun 27, 2020 | $10.53M | – |
| Q4 FY2020CQ1 2020 | Mar 28, 2020 | $17.62M | -15.4% |
| Q3 FY2020CQ4 2019 | Dec 28, 2019 | $29.90M | – |
| Q2 FY2020CQ3 2019 | Sep 28, 2019 | $37.49M | +100.2% |
| Q1 FY2020CQ2 2019 | Jun 29, 2019 | -$8.48M | – |
| Q4 FY2019CQ1 2019 | Mar 30, 2019 | $20.84M | +75.4% |
| Q3 FY2019CQ4 2018 | Dec 29, 2018 | -$8.48M | – |
| Q2 FY2019CQ3 2018 | Sep 29, 2018 | $18.73M | -6.8% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$2.82M | -114.0% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $11.88M | – |
| Q3 FY2018CQ4 2017 | Dec 30, 2017 | -$6.55M | -142.5% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $20.10M | +1.4% |
| Q1 FY2018CQ2 2017 | Jul 1, 2017 | $20.14M | – |
| Q4 FY2017CQ1 2017 | Apr 1, 2017 | -$51.14M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $15.39M | – |
| Q2 FY2017CQ3 2016 | Oct 1, 2016 | $19.83M | – |
See a number that looks wrong?